O

    Oramed Pharmaceuticals Inc (ORMP)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $5.02
    -0.01 (-0.20%)

    Market Cap: $205.86M

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    64%(25/39)
    Avg Surprise
    +44.93%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.52
    Range$0.52 - $0.52
    1 analysts
    EPS Revisions
    1
    0
    7d
    No revisions (30d)
    EPS Estimate Drift
    90d ago$0.00-100.0%
    60d ago$0.00-100.0%
    30d ago$0.00-100.0%
    7d ago$0.19-63.5%
    Current$0.52
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    Dec 31, 2026
    EPS Consensus$1.36
    Range$1.36 - $1.36
    1 analysts
    Revenue Consensus
    $0
    Range$0 - $0
    1 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$1.36---
    Sep 26EST
    		-$0.52---
    Jun 26
    		$-0.09N/A-120.93%Miss-129.0%
    Mar 26
    		$0.91N/AN/ABeat+580.4%
    Dec 25
    		$0.25$-0.08+412.50%Beat+198.0%
    Sep 25
    		$1.13$-0.04+2925.00%Beat+335.4%
    Jun 25
    		$0.31$-0.04+875.00%Beat+40.9%
    Mar 25
    		$-0.19$-0.03-533.33%Miss-575.0%
    Dec 24
    		$-0.26$0.02-1376.00%Miss-177.3%
    Sep 24
    		$-0.48$-0.02-2300.00%Miss-500.0%
    Jun 24
    		$0.22$-0.02+1200.00%Beat+833.3%
    Mar 24
    		$0.04$0.02+100.00%Beat+150.0%
    Dec 23
    		$0.33$-0.12+375.00%Beat+250.0%
    Sep 23
    		$-0.08$-0.09+11.11%Beat+55.6%
    Jun 23
    		$-0.03N/A+66.67%Beat+88.9%
    Mar 23
    		$-0.08N/A+68.00%Beat+70.4%
    Dec 22
    		$-0.22$-0.23+4.35%Beat+0.0%
    Sep 22
    		$-0.18$-0.26+30.77%Beat+14.3%
    Jun 22
    		$-0.27$-0.24-12.50%Miss-58.8%
    Mar 22
    		$-0.27$-0.27+0.00%Beat-58.8%
    Dec 21
    		$-0.22$-0.16-37.50%Miss+4.3%
    Sep 21
    		$-0.21$-0.18-16.67%Miss-75.0%
    Jun 21
    		$-0.17$-0.24+29.17%Beat-70.0%
    Mar 21
    		$-0.17$-0.17+0.00%Beat+19.0%
    Dec 20
    		$-0.23$-0.19-21.05%Miss-53.3%
    Sep 20
    		$-0.12$-0.21+42.86%Beat+7.7%
    Jun 20
    		$-0.10$-0.20+50.00%Beat+56.5%
    Mar 20
    		$-0.21$-0.17-23.53%Miss+0.0%
    Dec 19
    		$-0.15$-0.23+34.78%Beat+40.0%
    Sep 19
    		$-0.13$-0.24+45.83%Beat+27.8%
    Jun 19
    		$-0.23$-0.24+4.17%Beat+23.3%
    Mar 19
    		$-0.21$-0.26+19.23%Beat-5.0%
    Dec 18
    		$-0.25$-0.19-31.58%Miss-38.9%
    Sep 18
    		$-0.18$-0.29+37.93%Beat+10.0%
    Jun 18
    		$-0.30$-0.27-11.11%Miss-100.0%
    Mar 18
    		$-0.20$-0.29+31.03%Beat+16.7%
    Dec 17
    		$-0.18$-0.21+14.29%Beat+10.0%
    Sep 17
    		$-0.20$-0.23+13.04%Beat+45.9%
    Jun 17
    		$-0.15$-0.27+44.44%Beat-
    Mar 17
    		$-0.24$-0.19-26.32%Miss-
    Dec 16
    		$-0.20$-0.12-66.67%Miss-
    Sep 16
    		$-0.37$-0.18-105.56%Miss-

    Dividends

    Dividend Metrics

    Yield4.98%
    Annual/Share$0.25
    Payout Ratio9.66%
    Pay MonthsJan

    Key Metrics

    Valuation
    P/E Ratio2.28EV/EBITDA2.14x
    Price/FCF-36.93xFCF Yield-2.71%
    Profitability
    Profit Margin0.00%Operating Margin0.00%
    ROE74.20%ROIC16.61%
    Financial Health
    Debt/Equity0.00xInterest Coverage1.99x
    Current Ratio4.98xQuick Ratio4.98x
    Trading Statistics
    Beta1.16Avg Volume228.08K
    52-Week High$5.4752-Week Low$1.95

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$4.97
    SMA 20$4.66
    SMA 50$4.41
    SMA 200$3.65
    EMA 10$4.94
    EMA 20$4.74
    EMA 50$4.45
    EMA 200$3.72

    MACD

    Line: 0.24Signal: 0.20Hist: 0.04

    ADX

    ADX: 38.6+DI: 29.9-DI: 11.9

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down16.0
    PSAR$4.84

    Bollinger Bands

    Upper Band$5.37
    Lower Band$3.95
    %B Position3042%(Upper)
    Band Width0.75

    RSI (14-Day)

    Neutral
    64.2

    Momentum Oscillators

    Stoch %K67.4
    Stoch %D77.1
    Williams %R-36.0
    ROC (10d)9.8%
    Momentum0.45
    CCI (20d)75.7
    MFI (14d)72.2

    Volatility Measures

    ATR (14d)$0.23(4.5%)
    StdDev (20d)0.35
    Hist Vol43.2%(High)

    Volume Flow

    VWAP$5.00
    OBV4.5M
    AD Line-67.4M
    CMF (20d)0.136

    Volume Metrics

    Avg Vol (20d)225.4K
    Vol Ratio1.1x
    VWMA (20d)$4.78

    Pivot Points

    R3$5.26
    R2$5.20
    R1$5.12
    Pivot Point$5.06
    S1$4.98
    S2$4.92
    S3$4.84

    Advanced Oscillators

    TSI33.84
    Ultimate Osc56.3
    KST161.74

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total RevenueN/A$0$0$0$0$2.00M$0$0$0$0$0$0
    Cost of RevenueN/A$30,000$30,000$31,000$30,000$1.99M$31,000$0$0$0$53,000N/A
    Gross ProfitN/A$-30,000$-30,000$-31,000$-30,000$13,000$-31,000$-52,000$-54,000$-56,000$-53,000N/A
    Operating Expenses$2.77M$3.66M$5.64M$2.40M$2.49M$4.51M$3.56M$3.09M$3.13M$2.96M$3.82M$2.89M
    R&D$0$1.59M$1.99M$1.15M$1.03M$2.21M$1.46M$2.24M$1.44M$1.18M$1.71M$957,000
    SG&A$2.77M$2.06M$3.68M$1.27M$1.46M$2.31M$2.13M$847,000$1.69M$1.78M$2.11M$2.60M
    Operating Income$-2,766,000$-3,659,000$-5,672,000$-2,427,000$-2,489,000$-4,500,000$-3,595,000$-3,089,000$-3,135,000$-2,962,000$-3,877,000$-2,893,000
    Interest Income$0$276,000$0$0$15.37M$647,000$1.10M$0$14.23M$5.09M$3.52M$435,000
    Interest Expense$0$0$337,000$0$0$2.56M$15.42M$15.42M$261,000$592,000$1.21M$826,000
    Income Before Tax$101.59M$49.44M$9.80M$59.45M$13.13M$-7,058,000$-9,783,000$-18,509,000$10.84M$1.53M$13.30M$-3,284,000
    Income Tax Expense$23.43M$11.13M$-212,000$11.06M$-126,000$584,000$416,000$1.13M$1.63M$0$0$373,000
    Net Income$78.16M$38.31M$10.01M$48.40M$13.29M$-7,642,000$-10,189,000$-19,619,000$9.21M$1.54M$13.34M$-3,222,000
    EBITDA$101.59M$-3,629,000$-5,642,000$59.48M$13.16M$-4,470,000$-3,564,000$-18,457,000$11.15M$2.18M$-3,824,000$-2,404,000
    EBITN/A$-3,659,000$-5,672,000$59.45M$13.13M$-4,500,000$-3,595,000$-18,509,000$11.10M$2.13M$-3,877,000$-2,458,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ORMP

    News

    Oramed Pharmaceuticals Incorporated Actuals & Estimates (TRADEGATE:OJU1)

    This article provides an overview of Oramed Pharmaceuticals Incorporated (TRADEGATE:OJU1), including its financial actuals and estimates, stock forecast, historical prices, and upcoming earnings date. It details analyst opinions, with a price estimate range of 5.29 EUR, and notes the company's net income for the last quarter was 68.43M EUR, with an EBITDA of -12.61M EUR. The article also provides information on how to track the company's financials and purchase its stocks.

    TradingView•8/19/26•
    Neutral

    Top Penny Stocks To Watch In August 2026

    This article identifies three penny stocks—Oramed Pharmaceuticals (ORMP), AGNT Inc. (AGNT), and Cerus Corporation (CERS)—as potential investment opportunities for August 2026. These companies are highlighted for their strong financial health, despite being in the volatile penny stock category. The analysis focuses on their balance sheet strength, growth potential, and current financial performance to help investors discover hidden value.

    Simply Wall Street•8/19/26•
    Bullish

    Top Penny Stocks To Watch In August 2026

    This article identifies three penny stocks—Oramed Pharmaceuticals (ORMP), AGNT (AGNT), and Cerus (CERS)—that combine strong balance sheets with potential for significant growth. Oramed Pharmaceuticals recently became profitable and is debt-free, while AGNT, despite being unprofitable, has an experienced management team and a dividend yield. Cerus has reduced its net loss and shows financial resilience, although investor concerns about profitability remain.

    Simply Wall Street•8/19/26•
    Bullish

    ORMP Price Today: Oramed Pharmaceuticals Inc. Stock Price, Quote & Chart | MEXC

    This article provides a detailed overview of Oramed Pharmaceuticals Inc. (ORMP) stock, including its current price, market data, and recent performance. It highlights that ORMP is trading at $4.49, reflecting a +2.40% movement, and has shown strong returns over the past month (+9.44%) and year (+115.72%). The company, classified in the Pharmaceutical Preparations sector, focuses on oral delivery of therapeutic proteins and has a market capitalization of $186.36 million.

    MEXC•8/15/26•
    Bullish

    Oramed Pharmaceuticals (NASDAQ:ORMP) Upgraded by Wall Street Zen to Buy Rating

    Wall Street Zen has upgraded Oramed Pharmaceuticals (NASDAQ:ORMP) from a "hold" to a "buy" rating, though MarketBeat's overall analyst rating for the company remains "Hold." Oramed Pharmaceuticals opened at $4.48, with a market capitalization of $186.35 million. The company recently reported a quarterly loss of $0.09 per share, missing the consensus estimate of $0.43, and corporate insiders have sold shares totaling over $940,000 in July.

    MarketBeat•8/15/26•
    Somewhat-Bullish

    Frequently Asked Questions About ORMP

    What is ORMP's current dividend yield?
    Oramed Pharmaceuticals Inc (ORMP) has a current dividend yield of 4.98%.
    Does ORMP pay dividends?
    Yes, Oramed Pharmaceuticals Inc pays dividends with a current yield of 4.98%.
    What is ORMP's P/E ratio?
    Oramed Pharmaceuticals Inc has a price-to-earnings (P/E) ratio of 2.28.
    What is ORMP's market cap?
    Oramed Pharmaceuticals Inc (ORMP) has a market capitalization of $205.86M with a current stock price of $5.02.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In